Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 28, 2026 07:25 ET | Source: Dyadic International, Inc.

Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development

Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development
May 27, 2026 08:00 ET | Source: Intravacc B.V.

Intravacc Secures French CIR Approval to Support Vaccine R&D Partnerships

The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services.
May 27, 2026 02:00 ET | Source: Intravacc B.V.

Intravacc Secures French CIR Approval to Support Vaccine R&D Partnerships

The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services.
May 27, 2026 02:00 ET | Source: Intravacc B.V.

Intravacc obtient l’agrément CIR en France pour accompagner ses partenariats en R&D vaccinale

Valable pour la période 2025–2027, cet agrément permet aux entreprises innovantes françaises de faire appel à l’expertise d’Intravacc dans le développement de vaccins, le développement analytique et...
May 27, 2026 02:00 ET | Source: Intravacc B.V.

Intravacc erhält Genehmigung der französischen CIR zur Unterstützung von Partnerschaften in der Impfstoffforschung und -entwicklung

Die Zulassung für den Zeitraum 2025–2027 ermöglicht französischen Innovatoren den Zugang zu den Dienstleistungen von Intravacc in den Bereichen Impfstoffentwicklung, analytische Entwicklung und...
May 26, 2026 08:00 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza

Novel, potent pan-viral inhibitors targeting the viral replication complex are under development for the treatment of hantavirus, bunyavirus and influenzaHantavirus and bunyavirus infections represent...
May 21, 2026 09:25 ET | Source: Research and Markets

Hepatitis A Market Research Report 2026-2036: Ecosystem, Marketed and Emerging Therapies, Epidemiological Analysis, Pipeline, Clinical Trial Landscape, Regulations Featuring GSK, Merck, and Sanofi

Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Hepatitis A Market - A Global and Regional Analysis: Focus on Vaccine Type, Application, Country, 2026-2036" report has been added to ...
May 21, 2026 04:09 ET | Source: Research and Markets

MRNA Vaccine and Therapeutics Market Research Trends and Forecast Report 2026-2035: Revolutionizing Protein Synthesis, Altering the Biomedical Scene and Paving the Way for Innovative Treatment Options

Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "mRNA Vaccine and Therapeutics Market (4th Edition) by Application Area, Target Disease Indication and Geographical Regions - Trends and Forecast, Till...
May 18, 2026 07:05 ET | Source: Kraig Biocraft Laboratories

Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications

Kraig Labs (OTCQB:KBLB) latest breakthrough could form the foundation for a next-generation biotechnology platform with potential applications in biopharma
May 14, 2026 13:11 ET | Source: Informed Consent Action Network

Award-Winning Film ‘An Inconvenient Study’ Being Blocked By Verizon

ICAN investigates reports that Verizon users cannot access the film website AnInconvenientStudy.com, raising censorship concerns.